Accrol Group appoints Chris Welsh as Chief Financial Officer

Accrol Group Holdings plc (LON:ACRL), the UK’s leading independent tissue converter, has announced that Chris Welsh has today joined the Board as Chief Financial Officer.

As detailed in the HY23 Results announcement, Chris succeeds Richard Newman, who has now resigned as CFO and stepped down from the Board but, to ensure a smooth transition, has agreed to remain with the Company until the FY23 audit process is completed and the Final Results are released.

Chris joined the business in October 2022, as part of the Board’s succession planning. Before his move to Accrol, Chris held several senior finance roles at the multinational chemical manufacturing group, Ineos, most latterly as Head of Financial Reporting at the Enterprises Division.

Chris is a Chartered Accountant, who qualified with PwC in 2015.

Gareth Jenkins, Chief Executive Officer, said:

“We are delighted to welcome Chris to the Board. Since joining Accrol last year, he has been operating at the highest standard, demonstrating the commitment, energy and acumen which will help deliver our strategic objectives.

“I would also like to take this opportunity to thank Richard for his significant contribution to the Group. On appointment, he was tasked with transforming the finance function of the business, which he has achieved. Richard hands over to Chris a much strengthened finance team and infrastructure, capable of serving a much larger business.”

Further information relating to Christopher Welsh

In accordance with Schedule 2(g) of the AIM rules, Christopher (“Chris”) James Welsh (aged 33) holds or has held in the past five years the following directorships:

Current directorships

·Accrol UK Limited
·LTC Parent Ltd
·John Dale Holdings Limited
·Leicester Tissue Company Limited
·Art Tissue Ltd
·Accrol Papers Limited
·Accrol Holdings Limited
·John Dale Limited

Chris holds no shares in the Company.

There is no further information on Chris required to be disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Accrol Group

More articles like this

Accrol Group

What are the latest technology trends in manufacturing?

We asked the FactoryTech 50 and judging panel to describe a particular trend they have noticed in manufacturing technology in the last year. Judge Kevin Smith (below) is lead technology advisor at Made Smarter UK, which has engaged

Accrol Group

UK Manufacturing industry shows growth and recovery in March

The UK’s manufacturing industry has returned to growth and is showing “tentative signs of recovery”, according to a closely-watched survey. Both output and new orders increased in March, while business optimism also hit an 11-month high,

Accrol Group

British manufacturing sees surge in sales and job creation

British manufacturing is witnessing a Brexit boost as sales rocket in the EU, Middle East and Far East, and the lifeblood of the UK economy flows once more. Major players in automotive, aerospace, construction, electrification, and

Accrol Group

Accrol Group Holdings Results Presentation 2024 (VIDEO)

Accrol Group Holdings (LON:ACRL) CEO Gareth Jenkins and CFO Chris Welsh present its latest results and company overview. Accrol Group Holdings is the UK’s leading independent tissue converter, producing toilet tissue, kitchen towels, facial tissue and biodegradable

Accrol Group

Greenarc partnered with Accrol to install onsite EV chargers

Accrol Group Holdings plc (LON:ACRL) is the UK’s leading independent tissue converter, producing toilet tissue, kitchen towel, facial tissue and biodegradable wet wipes. The UK soft tissue market is worth £1.6bn with private label products comprising